Stockscreener 앱 받기
82.41
1.82%
1.47
시간 외 거래:
82.33
-0.08
-0.10%
전일 마감가:
$80.94
열려 있는:
$81.99
하루 거래량:
320.94K
Relative Volume:
0.62
시가총액:
$3.16B
수익:
-
순이익/손실:
$-241.60M
주가수익비율:
-12.45
EPS:
-6.6167
순현금흐름:
$-201.34M
1주 성능:
+2.76%
1개월 성능:
+11.18%
6개월 성능:
+23.20%
1년 성능:
+38.71%
1일 변동 폭
$81.77
$83.59
1주일 범위
$77.99
$83.59
52주 변동 폭
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
82.41 | 3.03B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
552.85 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
833.56 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,019.49 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
158.83 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.38 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 재개 | Stifel | Buy |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-06-11 | 재개 | Raymond James | Strong Buy |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Will FDA Bitopertin Rejection and New Legal Probe Change Disc Medicine's (IRON) Narrative? - Sahm
Disc (IRON) Quarterly Figures: EPS Exceeds Its Estimate for the Current Session; Price Reaction: Shares Move 1.84% Lower in the Available RecordQuarterly Earnings - vinanet.vn
Rosen Law Firm investigates Disc Medicine over potential securities claims - scanx.trade
Handelsbanken Fonder AB Buys Shares of 12,700 Disc Medicine, Inc. $IRON - MarketBeat
Disc (IRON) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Trading Move - vinanet.vn
Disc Medicine CEO John Quisel sells $2.6m in shares By Investing.com - Investing.com Australia
Disc Medicine CEO John Quisel sells $2.6m in shares - Investing.com
Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares - Bitget
Insider Selling: Disc Medicine (NASDAQ:IRON) CEO Sells 33,000 Shares of Stock - MarketBeat
Disc Medicine (IRON) CEO sells 33K shares under trading plan - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
GSA Capital Partners LLP Takes $1.19 Million Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine faces class action after FDA reje... - Pluang
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
Disc Medicine (NASDAQ: IRON) insider to sell 33,000 shares via plan - Stock Titan
Disc Medicine (IRON) Pulls Back 1.46% to $78.84 as Shares Test Key Resistance ZoneExhaustion Gap - vinanet.vn
Disc Medicine (IRON) Slips 1.46% as Biotech Consolidates Near Key SupportCovered Call ETF - Vinanet
Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com - Investing.com Australia
Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares - MarketBeat
Disc Medicine COO Jonathan Yu sells $66,444 in shares - Investing.com
Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Sei Investments Co. Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
FMR LLC Trims Disc Medicine Inc (IRON) Stake: A Strategic Reduction Amid Biotech Volatility - GuruFocus
Disc Medicine, Inc. (IRON) Investor Outlook: Potential 29% Upside Ignites Interest - DirectorsTalk Interviews
Renaissance Technologies LLC Sells 31,000 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Price-Driven Insight from (IRON) for Rule-Based Strategy - Stock Traders Daily
The Manufacturers Life Insurance Company Decreases Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Shares Sold by Assenagon Asset Management S.A. - MarketBeat
HC Wainwright Decreases Earnings Estimates for Disc Medicine - MarketBeat
Disc Medicine Inc (IRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares By Investing.com - Investing.com Australia
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares - Investing.com
Disc Medicine (NASDAQ:IRON) Insider Rahul Khara Sells 5,000 Shares - MarketBeat
Disc Medicine Chief Legal Officer Rahul Khara disposes of 5,000 common shares for $400,000 - Bitget
Disc Medicine Insider Sold Shares Worth $400,000, According to a Recent SEC Filing - Moomoo
Disc Medicine (NASDAQ: IRON) CLO sells 5,000 shares after option exercise - Stock Titan
FY2029 EPS Estimates for Disc Medicine Lowered by Analyst - marketbeat.com
IRON (IRON) filer plans 5,000-share stock sale after option exercise - Stock Titan
Disc Medicine (IRON): FMR LLC, Abigail Johnson report 12.8% ownership of common stock - Stock Titan
HC Wainwright Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
IRON Maintained by HC Wainwright & Co. -- Price Target Raised to $120 - GuruFocus
H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Announces Target Price $120 - Moomoo
Dimensional Fund Advisors LP Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Slips 1.86% as Biotech Stock Tests Key Support ZoneAnalyst Upgrade Stocks - vinanet.vn
Disc Medicine, Inc. Revenue Breakdown – NASDAQ:IRON - TradingView
Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 32% Potential Upside with Strong Buy Ratings - directorstalkinterviews.com
Lazard Asset Management LLC Lowers Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Bank of New York Mellon Corp Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Disc Medicine Inc 주식 (IRON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Quisel John D | Chief Executive Officer |
Aug 17 '26 |
Sale |
79.15 |
33,000 |
2,611,982 |
226,064 |
0.07%
1.21%
자본화:
|
볼륨(24시간):